313 related articles for article (PubMed ID: 29579760)
21. Safety and efficacy of lithium in children and adolescents: A systematic review in bipolar illness.
Amerio A; Ossola P; Scagnelli F; Odone A; Allinovi M; Cavalli A; Iacopelli J; Tonna M; Marchesi C; Ghaemi SN
Eur Psychiatry; 2018 Oct; 54():85-97. PubMed ID: 30130637
[TBL] [Abstract][Full Text] [Related]
22. Lithium specificity in bipolar illness: a classic agent for the classic disorder.
Gershon S; Chengappa KN; Malhi GS
Bipolar Disord; 2009 Jun; 11 Suppl 2():34-44. PubMed ID: 19538684
[TBL] [Abstract][Full Text] [Related]
23. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.
Amare AT; Thalamuthu A; Schubert KO; Fullerton JM; Ahmed M; Hartmann S; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hou L; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Hasler R; Richard-Lepouriel H; Perroud N; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Del Zompo M; DePaulo JR; Étain B; Jamain S; Falkai P; Forstner AJ; Frisen L; Frye MA; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Fallgatter AJ; Stegmaier S; Ethofer T; Biere S; Petrova K; Schuster C; Adorjan K; Budde M; Heilbronner M; Kalman JL; Kohshour MO; Reich-Erkelenz D; Schaupp SK; Schulte EC; Senner F; Vogl T; Anghelescu IG; Arolt V; Dannlowski U; Dietrich D; Figge C; Jäger M; Lang FU; Juckel G; Konrad C; Reimer J; Schmauß M; Schmitt A; Spitzer C; von Hagen M; Wiltfang J; Zimmermann J; Andlauer TFM; Fischer A; Bermpohl F; Ritter P; Matura S; Gryaznova A; Falkenberg I; Yildiz C; Kircher T; Schmidt J; Koch M; Gade K; Trost S; Haussleiter IS; Lambert M; Rohenkohl AC; Kraft V; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Millischer V; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Veeh J; Witt SH; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Clark SR; Baune BT
Mol Psychiatry; 2023 Dec; 28(12):5251-5261. PubMed ID: 37433967
[TBL] [Abstract][Full Text] [Related]
24. The effect of lithium in bipolar disorder: a review of recent research evidence.
Maj M
Bipolar Disord; 2003 Jun; 5(3):180-8. PubMed ID: 12780872
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with lithium efficacy in bipolar disorder.
Rybakowski JK
Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
[TBL] [Abstract][Full Text] [Related]
26. A glutamatergic network mediates lithium response in bipolar disorder as defined by epigenome pathway analysis.
Higgins GA; Allyn-Feuer A; Barbour E; Athey BD
Pharmacogenomics; 2015; 16(14):1547-63. PubMed ID: 26343379
[TBL] [Abstract][Full Text] [Related]
27. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
[TBL] [Abstract][Full Text] [Related]
28. Molecular Signatures of Lithium Treatment: Current Knowledge.
Bellivier F; Marie-Claire C
Pharmacopsychiatry; 2018 Sep; 51(5):212-219. PubMed ID: 30060262
[TBL] [Abstract][Full Text] [Related]
29. Use of lithium in the treatment of bipolar disorder in late-life.
D'Souza R; Rajji TK; Mulsant BH; Pollock BG
Curr Psychiatry Rep; 2011 Dec; 13(6):488-92. PubMed ID: 21847537
[TBL] [Abstract][Full Text] [Related]
30. Novel integrative genomic tool for interrogating lithium response in bipolar disorder.
Hunsberger JG; Chibane FL; Elkahloun AG; Henderson R; Singh R; Lawson J; Cruceanu C; Nagarajan V; Turecki G; Squassina A; Medeiros CD; Del Zompo M; Rouleau GA; Alda M; Chuang DM
Transl Psychiatry; 2015 Feb; 5(2):e504. PubMed ID: 25646593
[TBL] [Abstract][Full Text] [Related]
31. [Lithium and bipolar disorder--a renaissance?].
Simhandl C; Mersch J
Neuropsychiatr; 2007; 21(2):121-30. PubMed ID: 17640498
[TBL] [Abstract][Full Text] [Related]
32. Lithium: the defining element?
Malhi GS; Gershon S
Aust N Z J Psychiatry; 2014 Nov; 48(11):973-4. PubMed ID: 25351911
[No Abstract] [Full Text] [Related]
33. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
34. Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis.
Lorettu L; Carpita B; Nivoli A; Milia P; De Iorio G; Cremone IM; DellʼOsso L
Clin Neuropharmacol; 2020; 43(5):158-161. PubMed ID: 32947427
[TBL] [Abstract][Full Text] [Related]
35. Expression of telomerase reverse transcriptase positively correlates with duration of lithium treatment in bipolar disorder.
Lundberg M; Biernacka JM; Lavebratt C; Druliner B; Ryu E; Geske J; Colby C; Boardman L; Frye M; Schalling M
Psychiatry Res; 2020 Apr; 286():112865. PubMed ID: 32114208
[TBL] [Abstract][Full Text] [Related]
36. Use of antipsychotic drugs and lithium in mania.
Cookson J
Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
[TBL] [Abstract][Full Text] [Related]
37. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
38. Response to lithium has a neurobiological signature.
Caye A; Passos IC; Kunz M; Kauer-Sant'anna M
Mol Psychiatry; 2020 Mar; 25(3):509-510. PubMed ID: 29691466
[No Abstract] [Full Text] [Related]
39. [Lithium can be given to patients on haemodialysis treatment].
Kancir AS; Viftrup JE; Pedersen EB
Ugeskr Laeger; 2015 Jan; 177(2A):60-1. PubMed ID: 25612969
[TBL] [Abstract][Full Text] [Related]
40. Bipolar disorder.
Belmaker RH
N Engl J Med; 2004 Jul; 351(5):476-86. PubMed ID: 15282355
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
